晶泰控股-P早盘涨逾12% 近期与优时比签署大分子药物发现AI平台授权协议

新浪港股
28 Jan
热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易
客户端

  晶泰控股-P(02228)早盘上涨11.72%,现报5.53港元,成交额1.44亿港元。

  消息面上,1月9日,晶泰科技宣布,其下属部门Ailux Biologics与总部位于比利时的跨国生物制药公司优时比(UCB)签署大分子药物发现AI平台授权协议。根据协议,晶泰科技商业授权UCB使用Ailux Biologics自主开发的 XtalFold™ AI平台进行大分子药物的发现和工程化设计。公开资料显示,晶泰科技已成功辅助至少10款药物上市。

海量资讯、精准解读,尽在新浪财经APP

责任编辑:卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10